Literature DB >> 28280223

Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of 18F-FDG PET Data.

Marco Pagani1,2, Alessandro Giuliani3, Johanna Öberg4, Fabrizio De Carli5, Silvia Morbelli6, Nicola Girtler7,8, Dario Arnaldi7, Jennifer Accardo7, Matteo Bauckneht6, Francesca Bongioanni6, Andrea Chincarini9, Gianmario Sambuceti6, Cathrine Jonsson4, Flavio Nobili7.   

Abstract

Brain connectivity has been assessed in several neurodegenerative disorders investigating the mutual correlations between predetermined regions or nodes. Selective breakdown of brain networks during progression from normal aging to Alzheimer disease dementia (AD) has also been observed.
Methods: We implemented independent-component analysis of 18F-FDG PET data in 5 groups of subjects with cognitive states ranging from normal aging to AD-including mild cognitive impairment (MCI) not converting or converting to AD-to disclose the spatial distribution of the independent components in each cognitive state and their accuracy in discriminating the groups.
Results: We could identify spatially distinct independent components in each group, with generation of local circuits increasing proportionally to the severity of the disease. AD-specific independent components first appeared in the late-MCI stage and could discriminate converting MCI and AD from nonconverting MCI with an accuracy of 83.5%. Progressive disintegration of the intrinsic networks from normal aging to MCI to AD was inversely proportional to the conversion time.
Conclusion: Independent-component analysis of 18F-FDG PET data showed a gradual disruption of functional brain connectivity with progression of cognitive decline in AD. This information might be useful as a prognostic aid for individual patients and as a surrogate biomarker in intervention trials.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET; Alzheimer disease; independent-component analysis; mild cognitive impairment; normal aging

Mesh:

Substances:

Year:  2017        PMID: 28280223     DOI: 10.2967/jnumed.116.184309

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

2.  18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.

Authors:  Silvia Morbelli; Matteo Bauckneht; Dario Arnaldi; Agnese Picco; Matteo Pardini; Andrea Brugnolo; Ambra Buschiazzo; Marco Pagani; Nicola Girtler; Alberto Nieri; Andrea Chincarini; Fabrizio De Carli; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-07       Impact factor: 9.236

3.  On the Extraction and Analysis of Graphs From Resting-State fMRI to Support a Correct and Robust Diagnostic Tool for Alzheimer's Disease.

Authors:  Claudia Bachmann; Heidi I L Jacobs; PierGianLuca Porta Mana; Kim Dillen; Nils Richter; Boris von Reutern; Julian Dronse; Oezguer A Onur; Karl-Josef Langen; Gereon R Fink; Juraj Kukolja; Abigail Morrison
Journal:  Front Neurosci       Date:  2018-09-28       Impact factor: 4.677

4.  A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment.

Authors:  Min Wang; Zhuangzhi Yan; Shu-Yun Xiao; Chuantao Zuo; Jiehui Jiang
Journal:  Behav Neurol       Date:  2020-08-18       Impact factor: 3.342

5.  Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease.

Authors:  Jiehui Jiang; Min Wang; Ian Alberts; Xiaoming Sun; Taoran Li; Axel Rominger; Chuantao Zuo; Ying Han; Kuangyu Shi; For The Alzheimer's Disease Neuroimaging Initiative
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-15       Impact factor: 10.057

6.  Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.

Authors:  Fabrizio De Carli; Flavio Nobili; Marco Pagani; Matteo Bauckneht; Federico Massa; Matteo Grazzini; Cathrine Jonsson; Enrico Peira; Silvia Morbelli; Dario Arnaldi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-31       Impact factor: 9.236

7.  The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.

Authors:  Sanne K Meles; Marco Pagani; Dario Arnaldi; Fabrizio De Carli; Barbara Dessi; Silvia Morbelli; Gianmario Sambuceti; Cathrine Jonsson; Klaus L Leenders; Flavio Nobili
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-20       Impact factor: 6.200

8.  Radiomics and supervised machine learning in the diagnosis of parkinsonism with FDG PET: promises and challenges.

Authors:  Shichun Peng; Phoebe G Spetsieris; David Eidelberg; Yilong Ma
Journal:  Ann Transl Med       Date:  2020-07

9.  Physical activity, brain tissue microstructure, and cognition in older adults.

Authors:  Robert J Dawe; Lei Yu; Sue E Leurgans; Bryan D James; Victoria N Poole; Konstantinos Arfanakis; Julie A Schneider; David A Bennett; Aron S Buchman
Journal:  PLoS One       Date:  2021-07-07       Impact factor: 3.240

10.  Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).

Authors:  Matteo Bauckneht; Andrea Chincarini; Roberta Piva; Dario Arnaldi; Nicola Girtler; Federico Massa; Matteo Pardini; Matteo Grazzini; Hulya Efeturk; Marco Pagani; Gianmario Sambuceti; Flavio Nobili; Silvia Morbelli
Journal:  Alzheimers Res Ther       Date:  2018-04-03       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.